Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Erythropoietin Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Erythropoietin Drugsmarket, defines the market attractiveness level of Recombinant Erythropoietin Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Erythropoietin Drugs industry, describes the types of Recombinant Erythropoietin Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Erythropoietin Drugs market and the development prospects and opportunities of Recombinant Erythropoietin Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Erythropoietin Drugs market in Chapter 13.
By Player:
F Hoffmann-La Roche Ltd
Intas Pharmaceuticals Ltd
Biocon Limited
Sun Pharmaceutical Industries Ltd
Roche
Amgen
Celltrion, Inc
F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd
LG Life Sciences Ltd
3SBio Group
Johnson & Johnson
Teva Pharmaceutical Industries Ltd
Kyowa Hakko Kirin
By Type:
rhEPO
Erythropoiesis-Stimulating Agents (ESA)
By End-User:
Chronic Kidney Disease
Cancer Related Anemia
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Erythropoietin Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Erythropoietin Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Erythropoietin Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Erythropoietin Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Erythropoietin Drugs Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Erythropoietin Drugs Consumption (2017-2022)
-
7.2 United States Recombinant Erythropoietin Drugs Consumption (2017-2022)
-
7.3 Europe Recombinant Erythropoietin Drugs Consumption (2017-2022)
-
7.4 China Recombinant Erythropoietin Drugs Consumption (2017-2022)
-
7.5 Japan Recombinant Erythropoietin Drugs Consumption (2017-2022)
-
7.6 India Recombinant Erythropoietin Drugs Consumption (2017-2022)
-
7.7 South Korea Recombinant Erythropoietin Drugs Consumption (2017-2022)
8 Region and Country-wise Recombinant Erythropoietin Drugs Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
-
8.4 China Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
-
8.6 India Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Erythropoietin Drugs Consumption Forecast (2022-2028)
9 Global Recombinant Erythropoietin Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Erythropoietin Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global rhEPO Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Erythropoiesis-Stimulating Agents (ESA) Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Erythropoietin Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Kidney Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Related Anemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Recombinant Erythropoietin Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global rhEPO Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Erythropoiesis-Stimulating Agents (ESA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chronic Kidney Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Related Anemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Erythropoietin Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Erythropoietin Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Erythropoietin Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Erythropoietin Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Erythropoietin Drugs Market Competitive Analysis
-
14.1 F Hoffmann-La Roche Ltd
-
14.1.1 F Hoffmann-La Roche Ltd Company Details
-
14.1.2 F Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 F Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product and Service
-
14.2 Intas Pharmaceuticals Ltd
-
14.2.1 Intas Pharmaceuticals Ltd Company Details
-
14.2.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product and Service
-
14.3 Biocon Limited
-
14.3.1 Biocon Limited Company Details
-
14.3.2 Biocon Limited Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biocon Limited Recombinant Erythropoietin Drugs Product and Service
-
14.4 Sun Pharmaceutical Industries Ltd
-
14.4.1 Sun Pharmaceutical Industries Ltd Company Details
-
14.4.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Recombinant Erythropoietin Drugs Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Recombinant Erythropoietin Drugs Product and Service
-
14.7 Celltrion, Inc
-
14.7.1 Celltrion, Inc Company Details
-
14.7.2 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Celltrion, Inc Recombinant Erythropoietin Drugs Product and Service
-
14.8 F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd
-
14.8.1 F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd Company Details
-
14.8.2 F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd Recombinant Erythropoietin Drugs Product and Service
-
14.9 LG Life Sciences Ltd
-
14.9.1 LG Life Sciences Ltd Company Details
-
14.9.2 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product and Service
-
14.10 3SBio Group
-
14.10.1 3SBio Group Company Details
-
14.10.2 3SBio Group Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 3SBio Group Recombinant Erythropoietin Drugs Product and Service
-
14.11 Johnson & Johnson
-
14.11.1 Johnson & Johnson Company Details
-
14.11.2 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Johnson & Johnson Recombinant Erythropoietin Drugs Product and Service
-
14.12 Teva Pharmaceutical Industries Ltd
-
14.12.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.12.2 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Service
-
14.13 Kyowa Hakko Kirin
-
14.13.1 Kyowa Hakko Kirin Company Details
-
14.13.2 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Erythropoietin Drugs
-
Figure Recombinant Erythropoietin Drugs Picture
-
Table Global Recombinant Erythropoietin Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Erythropoietin Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Erythropoietin Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Erythropoietin Drugs Consumption by Country (2017-2022)
-
Figure United States Recombinant Erythropoietin Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Erythropoietin Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Erythropoietin Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Erythropoietin Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Erythropoietin Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Erythropoietin Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Erythropoietin Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Erythropoietin Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global rhEPO Consumption and Growth Rate (2017-2022)
-
Figure Global Erythropoiesis-Stimulating Agents (ESA) Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Kidney Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Related Anemia Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global rhEPO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erythropoiesis-Stimulating Agents (ESA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Kidney Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Related Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Erythropoietin Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Erythropoietin Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product and Service
-
Table Intas Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product and Service
-
Table Biocon Limited (Foundation Year, Company Profile and etc.)
-
Table Biocon Limited Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited Recombinant Erythropoietin Drugs Product and Service
-
Table Sun Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Recombinant Erythropoietin Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant Erythropoietin Drugs Product and Service
-
Table Celltrion, Inc (Foundation Year, Company Profile and etc.)
-
Table Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion, Inc Recombinant Erythropoietin Drugs Product and Service
-
Table F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Sun Pharmaceutical Industries Ltd Ltd Recombinant Erythropoietin Drugs Product and Service
-
Table LG Life Sciences Ltd (Foundation Year, Company Profile and etc.)
-
Table LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product and Service
-
Table 3SBio Group (Foundation Year, Company Profile and etc.)
-
Table 3SBio Group Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3SBio Group Recombinant Erythropoietin Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Recombinant Erythropoietin Drugs Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product and Service
-
